Rafael Holdings, Inc. - Net Worth and Insider Trading

Rafael Holdings, Inc. Net Worth

The estimated net worth of Rafael Holdings, Inc. is at least $5 Million dollars as of 2024-11-13. Rafael Holdings, Inc. is the 10% Owner of Cyclo Therapeutics Inc and owns about 6,514,970 shares of Cyclo Therapeutics Inc (CYTH) stock worth over $5 Million. Details can be seen in Rafael Holdings, Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rafael Holdings, Inc. has not made any transactions after 2023-08-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Rafael Holdings, Inc.

To

Rafael Holdings, Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rafael Holdings, Inc. owns 1 companies in total, including Cyclo Therapeutics Inc (CYTH) .

Click here to see the complete history of Rafael Holdings, Inc.’s form 4 insider trades.

Insider Ownership Summary of Rafael Holdings, Inc.

Ticker Comapny Transaction Date Type of Owner
CYTH Cyclo Therapeutics Inc 2023-08-01 10 percent owner

Rafael Holdings, Inc. Latest Holdings Summary

Rafael Holdings, Inc. currently owns a total of 1 stock. Rafael Holdings, Inc. owns 6,514,970 shares of Cyclo Therapeutics Inc (CYTH) as of August 1, 2023, with a value of $5 Million.

Latest Holdings of Rafael Holdings, Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTH Cyclo Therapeutics Inc 2023-08-01 6,514,970 0.74 4,821,078

Holding Weightings of Rafael Holdings, Inc.


Rafael Holdings, Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Rafael Holdings, Inc. has made a total of 1 transactions in Cyclo Therapeutics Inc (CYTH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cyclo Therapeutics Inc is the acquisition of 4,000,000 shares on August 1, 2023, which cost Rafael Holdings, Inc. around $5 Million.

Insider Trading History of Rafael Holdings, Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rafael Holdings, Inc. Trading Performance

GuruFocus tracks the stock performance after each of Rafael Holdings, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rafael Holdings, Inc. is -33.49%. GuruFocus also compares Rafael Holdings, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Rafael Holdings, Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rafael Holdings, Inc.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rafael Holdings, Inc.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.41 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.74 LIMIT LIMIT LIMIT LIMIT LIMIT

Rafael Holdings, Inc. Ownership Network

Ownership Network List of Rafael Holdings, Inc.

No Data

Ownership Network Relation of Rafael Holdings, Inc.

Insider Network Chart

Rafael Holdings, Inc. Owned Company Details

What does Cyclo Therapeutics Inc do?

Who are the key executives at Cyclo Therapeutics Inc?

Rafael Holdings, Inc. is the 10 percent owner of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include director & Chief Executive Officer Jeffrey Tate , SVP for Medical Affairs Sharon Hemond Hrynkow , and Chief Medical Officer Lise Lund Kjems .

Cyclo Therapeutics Inc (CYTH) Insider Trades Summary

Over the past 18 months, Rafael Holdings, Inc. made 1 insider transaction in Cyclo Therapeutics Inc (CYTH) with a net purchase of 4,000,000.

In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc (CYTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc (CYTH) were sold and 4,000,000 shares were bought by its insiders, resulting in a net purchase of 4,000,000 shares.

Cyclo Therapeutics Inc (CYTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cyclo Therapeutics Inc Insider Transactions

No Available Data

Rafael Holdings, Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Rafael Holdings, Inc.. You might contact Rafael Holdings, Inc. via mailing address: 520 Broad Street, Newark Nj 07120.